Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    18378608 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: quality-of-life assessment
2 Active, not recruiting Selenium for Prevention of Adenomatous Colorectal Polyps
Conditions: Colorectal Cancer;   Adenomatous Colorectal Polyps;   Precancerous Condition
Intervention: Drug: Selenium
3 Completed Laser and Medical Treatment of Diabetic Macular Edema
Condition: Macular Degeneration
Intervention: Drug: Celecoxib (Celebrex)
4 Completed Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
Condition: Colorectal Adenoma
Intervention: Drug: Celecoxib
5 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)

Study has passed its completion date and status has not been verified in more than two years.